Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) EBT (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed EBT for 13 consecutive years, with $4.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 17611.11% year-over-year to $4.7 million, compared with a TTM value of -$200.3 million through Dec 2025, down 117.99%, and an annual FY2025 reading of -$200.3 million, down 117.99% over the prior year.
  • EBT was $4.7 million for Q4 2025 at Tandem Diabetes Care, up from -$25.2 million in the prior quarter.
  • Across five years, EBT topped out at $11.1 million in Q4 2021 and bottomed at -$123.6 million in Q1 2023.
  • Average EBT over 5 years is -$29.5 million, with a median of -$23.9 million recorded in 2024.
  • The sharpest move saw EBT plummeted 909.66% in 2022, then surged 17611.11% in 2025.
  • Year by year, EBT stood at $11.1 million in 2021, then tumbled by 244.93% to -$16.2 million in 2022, then crashed by 94.12% to -$31.4 million in 2023, then surged by 99.91% to -$27000.0 in 2024, then soared by 17611.11% to $4.7 million in 2025.
  • Business Quant data shows EBT for TNDM at $4.7 million in Q4 2025, -$25.2 million in Q3 2025, and -$57.7 million in Q2 2025.